Methionine synthase A2756G polymorphism and breast cancer risk: An up-to-date meta-analysis

Gene

Volumn 527, Issue 2, 2013, Pages 510-515

  Zhong, Shanliang ^a   Xu, Jinjin ^a   Li, Wenjing ^b   Chen, Zhiyuan ^c   Ma, Tengfei ^a   Zhao, Jianhua ^a  

^a JIANGSU CANCER HOSPITAL   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

A2756G; Breast cancer; Meta analysis; MTR; Polymorphism; Susceptibility

Indexed keywords

METHIONINE SYNTHASE;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM;

A2756G; BREAST CANCER; CI; CONFIDENCE INTERVAL; HARDY-WEINBERG EQUILIBRIUM; HB; HOSPITAL-BASED; HWE; MALDI-TOF-MS; MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY; META-ANALYSIS; METHIONINE SYNTHASE; MTR; NEWCASTLE-OTTAWA SCALE; NOS; ODDS RATIO; OR; PB; PCR-RFLP; POLYMERASE CHAIN REACTION-RESTRICTION FRAGMENT LENGTH POLYMORPHISM; POLYMORPHISM; POPULATION-BASED; SINGLE NUCLEOTIDE POLYMORPHISM, LD, LINKAGE DISEQUILIBRIUM; SNP; SUSCEPTIBILITY;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC;

EID: 84881551347     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.06.054     Document Type: Article

References (44)

1. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
2. Carvalho Barbosa Rde C., Menezes D.C., Freire T.F., Sales D.C., Alencar V.H., Rabenhorst S.H. Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent. Mol. Biol. Rep. 2012, 39:4899-4907.
3. Chen L.H., Liu M.L., Hwang H.Y., Chen L.S., Korenberg J., Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J. Biol. Chem. 1997, 272:3628-3634.
4. Chen J., et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001, 154:667-672.
5. Cheng C.W., et al. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res. Treat. 2008, 111:145-155.
6. de Cassia Carvalho Barbosa R., da Costa D.M., Cordeiro D.E., Vieira A.P., Rabenhorst S.H. Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil. Anticancer. Res. 2012, 32:4805-4811.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clin. Trials 1986, 7:177-188.
8. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
9. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
10. Fodinger M., Horl W.H., Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J. Nephrol. 2000, 13:20-33.
11. Fredriksen A., Meyer K., Ueland P.M., Vollset S.E., Grotmol T., Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum. Mutat. 2007, 28:856-865.
12. Han L.L., Hou L., Song J.L. Genetic polymorphisms of methionine synthase, methylation of CHD5, and their association with breast cancer morbidity. China Oncol. 2010, 20:251-255.
13. Han H., Han L.L., Gao H.D., Hou L. Genetic polymorphisms of methylenetetrahydrofolate reductase, methionine synthase, methylation of NF2, and their association with breast cancer morbidity. Chin. J. Curr. Adv. Gen. Surg. 2011, 14:846-850.
14. Harmon D.L., et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet. Epidemiol. 1999, 17:298-309.
15. Hua Z.P., Wang Y.B., Ni J., Ge F., Zou T.N. Folic acid, Vitamin B12, MTHFR, MS gene polymorphisms associate with the risk of breast cancer. Mod. Oncol. 2011, 19:428-431.
16. Justenhoven C., et al. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol., Biomarkers Prev. 2005, 14:3015-3018.
17. Kim O.J., et al. Influence of combined methionine synthase (MTR 2756A>G) and methylenetetrahydrofolate reductase (MTHFR 677C>T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke. Yonsei Med. J. 2007, 48:201-209.
18. Kotsopoulos J., et al. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res. Treat. 2008, 112:585-593.
19. Lissowska J., et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int. J. Cancer 2007, 120:2696-2703.
20. Lu M., Wang F., Qiu J. Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects. Breast Cancer Res. Treat. 2010, 123:213-217.
21. Ma E., et al. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 2009, 9:122.
22. Ma E., et al. Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr. Cancer 2009, 61:447-456.
23. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
24. Naushad S.M., Pavani A., Digumarti R.R., Gottumukkala S.R., Kutala V.K. Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancer. Mol. Biol. Rep. 2011, 38:4893-4901.
25. Naushad S.M., et al. Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer. Mol. Carcinog. 2012, 51(Suppl. 1):E32-E41.
26. O'Brien J.M. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland, by P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki. N. Engl. J. Med. 2000, 343:78-84. (Surv Ophthalmol 45, 167-8).
27. Pabalan N., Jarjanazi H., Ozcelik H. A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations. Int. J. Colorectal Dis. 2013, 10.1007/s00384-013-1639-3.
28. Platek M.E., et al. Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol. Biomark. Prev. 2009, 18:2453-2459.
29. Qi X., et al. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res. Treat. 2010, 123:499-506.
30. Sangrajrang S., Sato Y., Sakamoto H., Ohnami S., Khuhaprema T., Yoshida T. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res. Treat. 2010, 123:885-893.
31. Sharp S. sbe23: meta-analysis regression. Stata Tech. Bull. 1998, 42:16-22.
32. Shrubsole M.J., et al. MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 2006, 15:586-588.
33. Stover P.J. Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 2004, 62:S3-S12. (discussion S13).
34. Suzuki T., et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008, 29:356-362.
35. Tao M.H., et al. DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol. Biomark. Prev. 2009, 18:998-1002.
36. Thakkinstian A., McElduff P., D'Este C., Duffy D., Attia J. A method for meta-analysis of molecular association studies. Stat. Med. 2005, 24:1291-1306.
37. Tsai M.Y., Bignell M., Yang F., Welge B.G., Graham K.J., Hanson N.Q. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 2000, 149:131-137.
38. Weiner A.S., et al. Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer Epidemiol. 2012, 36:e95-e100.
39. Wells G., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http://www.ohri.ca/programs/clinical_epidemiology/oxford_web.ppt.
40. Xu X., et al. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 2007, 28:1504-1509.
41. Yu C.P., et al. Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan. Anticancer. Res. 2007, 27:1727-1732.
42. Zintzaras E. Impact of Hardy-Weinberg equilibrium deviation on allele-based risk effect of genetic association studies and meta-analysis. Eur. J. Epidemiol. 2010, 25:553-560.
43. Zintzaras E., Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J. Clin. Epidemiol. 2008, 61:634-645.
44. Zintzaras E., Koufakis T., Ziakas P.D., Rodopoulou P., Giannouli S., Voulgarelis M. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur. J. Epidemiol. 2006, 21:501-510.